Pages that link to "Q51656578"
Jump to navigation
Jump to search
The following pages link to Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. (Q51656578):
Displaying 50 items.
- Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type (Q24617932) (← links)
- Treatment of diabetes with insulin. From art to science (Q33580637) (← links)
- Progressive deterioration of insulin secretion in Japanese type 2 diabetic patients in comparison with those who carry the S20G mutation of the islet amyloid polypeptide gene: A long-term follow-up study (Q33585856) (← links)
- Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes (Q33585873) (← links)
- Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetes. (Q33607736) (← links)
- Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function. (Q33607749) (← links)
- A Practical Review of C-Peptide Testing in Diabetes (Q33732640) (← links)
- Management of elderly diabetic patients in the subacute care setting (Q34031144) (← links)
- Increased incidence of true type I diabetes acquired during pregnancy (Q34068391) (← links)
- Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin (Q34297738) (← links)
- EDTA improves stability of whole blood C-peptide and insulin to over 24 hours at room temperature (Q34364493) (← links)
- Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus (Q34488457) (← links)
- Serum fructosamine concentrations in patients with type II (non-insulin-dependent) diabetes mellitus during changes in management (Q34548403) (← links)
- The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin? (Q34551020) (← links)
- Factors Associated with Long-Term Oral Hypoglycemic Agent Responsiveness in Korean Patients with Type 2 Diabetes Mellitus (Q35110336) (← links)
- C-Peptide Level in Fasting Plasma and Pooled Urine Predicts HbA1c after Hospitalization in Patients with Type 2 Diabetes Mellitus (Q35916079) (← links)
- Postprandial 2-hr C-peptide concentration as a guide for insulin treatment in patient with NIDDM. (Q35948175) (← links)
- Recognition of fasting or overall hyperglycaemia when starting insulin treatment in patients with type 2 diabetes in general practice (Q36048033) (← links)
- The clinical utility of C-peptide measurement in the care of patients with diabetes (Q37108880) (← links)
- Effect of interactions between C peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitus (Q37163138) (← links)
- Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use. (Q38618657) (← links)
- Factors of Importance for Residual Beta-cell Function in Type I Diabetes Mellitus (Q40154772) (← links)
- NIDDM in the Cat: Treatment with the Oral Hypoglycemic Medication, Glipizide (Q40474368) (← links)
- Cellular and humoural autoimmunity markers in type 2 (non-insulin-dependent) diabetic patients with secondary drug failure (Q41105523) (← links)
- Prevalence and Incidence of Diabetes in a Swedish Community 1972-1987 (Q41150896) (← links)
- Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus (Q42086492) (← links)
- Discrimination of type I from insulin-treated type II diabetic patients by C-peptide measurement (Q42522467) (← links)
- Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes (Q42526639) (← links)
- Diabetes in adolescent patients: diagnostic dilemmas (Q43598321) (← links)
- Type 1 (insulin-dependent) diabetes mellitus diagnosed during pregnancy: a clinical and prognostic study (Q43616025) (← links)
- Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus (Q43702115) (← links)
- Controlled multicenter study on the effect of computer assistance in intensive insulin therapy of type 1 diabetics (Q44052260) (← links)
- Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics (Q44537877) (← links)
- Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretion (Q44629598) (← links)
- Analysis ofHLA-DR and -DQ gene polymorphisms in sudanese patients with type 1 (insulin-dependent) diabetes (Q46951307) (← links)
- Early macular dysfunction detected by focal electroretinographic recording in non-insulin-dependent diabetics without retinopathy (Q47771580) (← links)
- Evaluation of beta-cell function in diabetic Taiwanese children using a 6-min glucagon test. (Q51463347) (← links)
- Diabetic microangiopathic complications in young Chinese diabetic patients: a clinic-based cross-sectional study (Q51557029) (← links)
- Determinants of a normal (versus impaired) oral glucose tolerance after combined pancreas-kidney transplantation in IDDM patients (Q51582008) (← links)
- Effects of early introduction of intensive insulin therapy on the clinical course in non-obese NIDDM patients (Q51589248) (← links)
- The effect of various blood glucose levels on post-glucagon C-peptide secretion in type 2 (non insulin-dependent) diabetes (Q51606922) (← links)
- A simple clinical approach to discriminate between "true" and "pseudo" secondary failure to oral hypoglycaemic agents (Q51607612) (← links)
- Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women (Q51612664) (← links)
- The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia (Q51618163) (← links)
- Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes (Q51621107) (← links)
- A comparison of serum C-peptide response to intravenous glucagon, and urine C-peptide, as indexes of insulin dependence (Q51636795) (← links)
- Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation (Q51636948) (← links)
- Plasma C-peptide Levels Identify Insulin-treated Diabetic Patients Suitable for Oral Hypoglycaemic Therapy (Q51640974) (← links)
- Islet cell autoimmunity in youth onset diabetes mellitus in Northern India. (Q54007902) (← links)
- INVESTIGATIONS IN CHILDREN WHO WERE IN UTERO AT ONSET OF INSULIN-DEPENDENT DIABETES IN THEIR MOTHERS (Q59488114) (← links)